# FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis

> **NCT06563765** · NA · ENROLLING_BY_INVITATION · sponsor: **Peking University First Hospital** · enrollment: 150 (estimated)

## Conditions studied

- CKD
- Renal Fibrosis

## Interventions

- **OTHER:** FAP-targeting PET/CT imaging will be performed on the enrolled patients.

## Key facts

- **NCT ID:** NCT06563765
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-04-10
- **Primary completion:** 2026-05-10
- **Final completion:** 2027-05-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06563765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06563765, "FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06563765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*